Related Experiment Videos
Present progress and future development in the therapy for Alzheimer's disease
1Department of Pharmacology, Southern Illinois University School of Medicine, Springfield 62794-9230.
Progress in Clinical and Biological Research
|January 1, 1989
Summary
This review explores four experimental Alzheimer disease (AD) therapies: genetic, neuropeptide, trophic factors, and cholinergic approaches. It analyzes current progress, challenges, and future directions for AD treatment development.
Area of Science:
- Neuroscience
- Pharmacology
- Genetics
Background:
- Alzheimer disease (AD) is a progressive neurodegenerative disorder with limited effective treatments.
- Experimental therapies aim to address the underlying pathology and symptoms of AD.
Purpose of the Study:
- To review current progress and future directions in experimental Alzheimer disease (AD) therapy.
- To analyze four distinct therapeutic approaches for AD.
Main Methods:
- Review of molecular genetic approaches.
- Analysis of neuropeptide delivery systems.
- Examination of trophic factor administration.
- Evaluation of cholinergic strategies.
Main Results:
- Discussion of the advantages and disadvantages of current experimental AD therapies.
- Presentation of the author's own experience and findings in AD research.
Conclusions:
- Experimental therapies for Alzheimer disease (AD) show promise but require further development.
- A multi-faceted approach combining different strategies may be necessary for effective AD treatment.